Aviva’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,962
Closed -$2.22M 1077
2022
Q1
$2.22M Sell
9,962
-1,058
-10% -$237K 0.01% 801
2021
Q4
$2.62M Buy
11,020
+2,797
+34% +$653K 0.01% 768
2021
Q3
$1.92M Buy
+8,223
New +$1.72M 0.01% 757
2021
Q2
Sell
-5,726
Closed -$1.18M 917
2021
Q1
$1.18M Sell
5,726
-925
-14% -$195K 0.01% 873
2020
Q4
$1.43M Sell
6,651
-5,391
-45% -$1.05M 0.01% 787
2020
Q3
$2.2M Sell
12,042
-635
-5% -$120K 0.01% 749
2020
Q2
$2.34M Buy
+12,677
New +$2.52M 0.01% 631

Other funds holding ICUI

Aviva's ICUI Position: Q2 2022 in Review

Aviva sold out of ICU Medical (ICUI) in Q2 2022, closing a stake of 9,962 shares — an estimated $2.22M sold.

Aviva first reported a position in ICUI in Q2 2020 and held it in 7 quarters. The position peaked at $2.62M in Q4 2021. 258 funds tracked by Wall St. Rank hold ICUI as of Q2 2022.

  • Aviva reported no remaining ICU Medical position as of Q2 2022 after selling out during the quarter.
  • Aviva sold 9,962 ICU Medical shares in Q2 2022, an estimated $2.22M.
  • Aviva first reported a position in ICU Medical in Q2 2020 and held it in 7 quarters.
  • Aviva's ICU Medical position peaked at $2.62M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held ICU Medical as of Q2 2022.

Based on Aviva's 13F filing for Q2 2022, filed 4 Aug 2022.